Robert P. Giannini
7Patents
5h-index
14Co-inventors
60Inventor score
Filing activity: Jul 12, 1985 → Jun 13, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4732892A | L-.alpha.-amino acids as transdermal penetration enhancers | Human Necessities | 53 | Expired |
| US4925675A | Erythromycin microencapsulated granules | Human Necessities | 29 | Expired |
| US4966770A | Prednisone microencapsulated granules | Human Necessities | 23 | Expired |
| US4925674A | Amoxicillin microencapsulated granules | Human Necessities | 15 | Expired |
| US4786509A | Dry sustained release theophylline oral formulation | Human Necessities | 9 | Expired |
| US11033520B2 | Liposomal anticancer compositions | Human Necessities | 1 | Active |
| US12343340B2 | Methods of using low dose naltrexone to treat chronic pain | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.